Arca
Skip to content
Tools
Tools

KCNJ2: Inward rectifier potassium channel 2

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who Is On It, and How Far Along

Every drug ChEMBL records acting on KCNJ2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved1

  • Dronedarone

Phase 30

    Phase 20

      Phase 10

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionMechanismOpen trialsWarnings
        DronedaroneApprovedSanofiSmall moleculeBlockerInward rectifier potassium channel 2 blocker8Boxed warning

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Efficacy of Early Rhythm Control in AF With TR PatientsDronedarone—RecruitingSamsung Medical Center2026-05-26
        Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial FibrillationDronedaroneNot applicableRecruitingSamsung Medical Center2026-03-03
        Dronedarone Rhythm Intervention for Early Atrial FibrillationDronedaronePhase 4Not yet recruitingInha University Hospital2025-12-08
        Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial FibrillationDronedaroneNot applicableRecruitingSeoul National University Hospital2024-11-21
        Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)DronedaroneNot applicableRecruitingThe First Affiliated Hospital with Nanjing Medical University2023-11-09
        Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationDronedaroneNot applicableActive, not recruitingBoston Scientific Corporation2023-10-23
        First-line Cryoablation for Early Treatment of Persistent Atrial FibrillationDronedaronePhase 3Not yet recruitingRegion Ă–rebro County2023-07-11
        Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKEDronedaronePhase 3RecruitingUniversitätsklinikum Hamburg-Eppendorf2022-03-24

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Andersen-Tawil syndrome
        0.84
        Short QT syndrome type 3
        0.71
        Short QT syndrome
        0.70
        Atrial fibrillation, familial, 9
        0.69
        Abnormality of the cardiovascular system
        0.54
        Cardiac arrhythmia
        0.52
        Periodic paralysis
        0.51
        Familial atrial fibrillation
        0.37
        Thyrotoxic periodic paralysis
        0.36

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1914276, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P63252, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.